Reports of Biochemistry
and Molecular Biology
Tue, Apr 23, 2024
[Archive]
Volume 9, Issue 1 (Vol.9 No.1 Apr 2020)
rbmb.net 2020, 9(1): 8-13 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Miraghaee S S, Sohrabi M, Jalili C, Bahrehmand F. Assessment of GSTO1 (A140D) and GSTO2 (N142D) Gene Polymorphisms in Iranian Women with Polycystic Ovarian Syndrome. rbmb.net 2020; 9 (1) :8-13
URL: http://rbmb.net/article-1-429-en.html
URL: http://rbmb.net/article-1-429-en.html
Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Abstract: (3811 Views)
Background: Glutathione S-transferases (GSTs) protect cells from oxidative stress (OS). In humans, the GST omega class contains two expressed genes, GSTO1 and GSTO2. Because OS is involved in the pathogenesis of polycystic ovary syndrome (PCOS), the aim of this study was to investigate the relationship between GSTO1 A140D (rs4925) and GSTO2 N142D (rs156697) polymorphisms in PCOS patients.
Methods: 175 PCOS patients and 161 healthy controls were selected among women in Kermanshah province, Iran. GSTO1 and GSTO2 were genotyped using allele-specific PCR (AS-PCR) and PCR-RFLP, respectively.
Results: For GSTO1, the DD genotype and the D allele led to 2.17- (P= 0.02) and 1.5-fold (P= 0.01) increases, respectively, in the odds ratios for PCOS. No significant difference was found between control and patient groups for the GSTO2 N142D genotype or allele frequency. GSTO1 and GSTO2 genotype interaction analysis showed that individuals with the GSTO1 AD or DD genotypes and the GSTO2 NN or DN genotypes had a 1.53-fold (P= 0.007) increase in PCOS risk over GSTO1 AA and GSTO2 DD individuals.
Conclusions: The GSTO1 A140D polymorphism is a risk factor for PCOS.
Methods: 175 PCOS patients and 161 healthy controls were selected among women in Kermanshah province, Iran. GSTO1 and GSTO2 were genotyped using allele-specific PCR (AS-PCR) and PCR-RFLP, respectively.
Results: For GSTO1, the DD genotype and the D allele led to 2.17- (P= 0.02) and 1.5-fold (P= 0.01) increases, respectively, in the odds ratios for PCOS. No significant difference was found between control and patient groups for the GSTO2 N142D genotype or allele frequency. GSTO1 and GSTO2 genotype interaction analysis showed that individuals with the GSTO1 AD or DD genotypes and the GSTO2 NN or DN genotypes had a 1.53-fold (P= 0.007) increase in PCOS risk over GSTO1 AA and GSTO2 DD individuals.
Conclusions: The GSTO1 A140D polymorphism is a risk factor for PCOS.
Type of Article: Original Article |
Subject:
Molecular Biology
Received: 2019/12/9 | Accepted: 2020/03/1 | Published: 2020/05/19
Received: 2019/12/9 | Accepted: 2020/03/1 | Published: 2020/05/19
References
1. Homburg R. What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome. Hum Reprod. 2002;17(10):2495-9. [DOI:10.1093/humrep/17.10.2495]
2. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29(2):181-191. [DOI:10.1016/S0002-9378(15)30642-6]
3. Franks S, Gharani N, McCarthy M. Candidate genes in polycystic ovary syndrome. Hum Reprod Update. 2001;7(4):405-10. [DOI:10.1093/humupd/7.4.405]
4. Demirci H, Yilmaz M, Ali Ergun M, Yurtcu E, Bukan N, Ayvaz G. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters. Gynecol Endocrinol. 2010;26(5):348-55. [DOI:10.3109/09513590903367051]
5. Salahshoor MR, Sohrabi M, Jalili F, Jalili P, Rezavand N, Haghnazari L, et al. No evidence for a major effect of three common polymorphisms of the GPx1, MnSOD, and CAT genes on PCOS susceptibility. J Cell Biochem. 2018. [DOI:10.1002/jcb.27564]
6. Zuo T, Zhu M, Xu W. Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev. 2016;2016: 8589318. [DOI:10.1155/2016/8589318]
7. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer. 2007;121(11):2381-6. [DOI:10.1002/ijc.23192]
8. Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive Oxygen Species (ROS)--Induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res. 2011;711(1-2):167-73. [DOI:10.1016/j.mrfmmm.2011.02.015]
9. Engin KN. Alpha-tocopherol: looking beyond an antioxidant. Mol Vis. 2009;15:855-60.
10. Pandey KB, Rizvi SI. Biomarkers of oxidative stress in red blood cells. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155(2):131-6. [DOI:10.5507/bp.2011.027]
11. Agusa T, Iwata H, Fujihara J, Kunito T, Takeshita H, Minh TB, et al. Genetic polymorphisms in glutathione S-transferase (GST) superfamily and arsenic metabolism in residents of the Red River Delta, Vietnam. Toxicol Appl Pharmacol. 2010;242(3):352-62. [DOI:10.1016/j.taap.2009.11.007]
12. Masoudi M, Saadat I, Omidvari S, Saadat M. Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep. 2009;36(4):781-4. [DOI:10.1007/s11033-008-9245-0]
13. Mukherjee B, Salavaggione OE, Pelleymounter LL, Moon I, Eckloff BW, Schaid DJ, et al. Erratum: Glutathione S-transferase omega 1 and omega 2 pharmacogenomics (Drug Metabolism and Disposition (2006) 34 (1237-1246)). Drug Metab Dispos. 2006;34(9):1666. [DOI:10.1124/dmd.34.9.1666]
14. Schmuck EM, Board PG, Whitbread AK, Tetlow N, Cavanaugh JA, Blackburn AC, et al. Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases. Pharmacogenet Genomics. 2005;15(7):493-501. [DOI:10.1097/01.fpc.0000165725.81559.e3]
15. Rezazadeh D, Moradi MT, Kazemi A, Mansouri K. Childhood Pre‐B acute lymphoblastic leukemia and glutathione S‐transferase omega 1 and 2 polymorphisms. Int J Lab Hematol. 2015;37(4):530-5. [DOI:10.1111/ijlh.12332]
16. Rotterdam, Eshre Asrm-Sponsored Pcos consensus workshop group. Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-7. [DOI:10.1093/humrep/deh098]
17. Moradi MT, Yari K, Khodarahmi R. A novel, efficient, fast and inexpensive DNA extraction protocol from whole blood applicable for studying drug-DNA interaction. J Rep Pharm Sci. 2014;3(1):80-84.
18. Savic-Radojevic A, Mazibrada I, Djukic T, Stankovic ZB, Pljesa-Ercegovac M, Sedlecky K, et al. Glutathione S-transferases (GSTs) polymorphism could be an early marker in the development of PCOS: an insight from non-obese and non-insulin resistant adolescents. Endokrynol Pol. 2018;69(4):366-374.
19. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51-88. [DOI:10.1146/annurev.pharmtox.45.120403.095857]
20. Knapen MF, Zusterzeel PL, Peters WH, Steegers EA. Glutathione and glutathione-related enzymes in reproduction. A review. Eur J Obstet Gynecol Reprod Biol. 1999;82(2):171-84. [DOI:10.1016/S0301-2115(98)00242-5]
21. Marahatta SB, Punyarit P, Bhudisawasdi V, Paupairoj A, Wongkham S, Petmitr S. Polymorphism of glutathione S-transferase omega gene and risk of cancer. Cancer Lett. 2006;236(2):276-81. [DOI:10.1016/j.canlet.2005.05.020]
22. Pongstaporn W, Rochanawutanon M, Wilailak S, Linasamita V, Weerakiat S, Petmitr S. Genetic alterations in chromosome 10q24. 3 and glutathione S-transferase omega 2 gene polymorphism in ovarian cancer. J Exp Clin Cancer Res. 2006;25(1):107-14.
23. Fanta M. Is polycystic ovary syndrome, a state of relative estrogen excess, a real risk factor for estrogen-dependant malignancies?. Gynecol Endocrinol. 2013;29(2):145-7. [DOI:10.3109/09513590.2012.730575]
24. Ada TG, Ada AO, Kunak SC, Alpar S, Gulhan M, Iscan M. Association between glutathione S-transferase omega 1 A140D polymorphism in the Turkish population and susceptibility to non-small cell lung cancer. Arh Hig Rada Toksikol. 2013;64(2):61-7. [DOI:10.2478/10004-1254-64-2013-2302]
25. Piacentini S, Monaci PM, Polimanti R, Manfellotto D, Fuciarelli M. GSTO2* N142D gene polymorphism associated with hypothyroidism in Italian patients. Mol Biol Rep. 2013;40(2):1967-71. [DOI:10.1007/s11033-012-2253-0]
26. Stamenkovic M, Radic T, Stefanovic I, Coric V, Sencanic I, Pljesa‐Ercegovac M, et al. Glutathione S‐transferase omega‐2 polymorphism Asn142Asp modifies the risk of age‐related cataract in smokers and subjects exposed to ultraviolet irradiation. Clin Exp Ophthalmol. 2014;42(3):277-83. [DOI:10.1111/ceo.12180]
27. Sharif MR, Sharif A, Kheirkhah D, Taghavi Ardakan M, Soltani N. Association of GSTO1 A140D and GSTO2 N142D Gene Variations with Breast Cancer Risk. Asian Pac J Cancer Prev. 2017;18(6):1723-1727.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
